Pyruvate dehydrogenase alpha 1 as a target of omega-3 polyunsaturated fatty acids in human prostate cancer through a global phosphoproteomic analysis

PROTEOMICS ◽  
2016 ◽  
Vol 16 (17) ◽  
pp. 2419-2431 ◽  
Author(s):  
Heng Zhao ◽  
Beth R. Pflug ◽  
Xianyin Lai ◽  
Mu Wang
2014 ◽  
Vol 352 (2) ◽  
pp. 380-394 ◽  
Author(s):  
Ze Liu ◽  
Mandi M. Hopkins ◽  
Zhihong Zhang ◽  
Chrystal B. Quisenberry ◽  
Louise C. Fix ◽  
...  

2011 ◽  
Vol 65 (Suppl 1) ◽  
pp. A290-A291
Author(s):  
A. A. Ur Rahman ◽  
A. Lophatananon ◽  
J. Lobaz ◽  
F. Robinson ◽  
S. S. Brown ◽  
...  

2015 ◽  
Vol 67 (4) ◽  
pp. 543-554 ◽  
Author(s):  
Dominik D. Alexander ◽  
Julie K. Bassett ◽  
Douglas L. Weed ◽  
Erin Cernkovich Barrett ◽  
Heather Watson ◽  
...  

Nutrients ◽  
2020 ◽  
Vol 12 (6) ◽  
pp. 1647
Author(s):  
Karin Yurko-Mauro ◽  
Mary Van Elswyk ◽  
Lynn Teo

This scoping review examines the interaction of docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) and genetic variants of various types of cancers. A comprehensive search was performed to identify controlled and observational studies conducted through August 2017. Eighteen unique studies were included: breast cancer (n = 2), gastric cancer (n = 1), exocrine pancreatic cancer (n = 1), chronic lymphocytic leukemia (n = 1), prostate cancer (n = 7) and colorectal cancer (n = 6). An additional 13 studies that focused on fish intake or at-risk populations were summarized to increase readers’ understanding of the topic based on this review, DHA and EPA interact with certain genetic variants to decrease breast, colorectal and prostate cancer risk, although data was limited and identified polymorphisms were heterogeneous. The evidence to date demonstrates that omega-3 long-chain polyunsaturated fatty acids (n-3 LC-PUFA) may decrease cancer risk by affecting genetic variants of inflammatory pathways, oxidative stress and tumor apoptosis. Collectively, data supports the notion that once a genetic variant is identified, the benefits of a targeted, personalized therapeutic regimen that includes DHA and/or EPA should be considered.


2013 ◽  
Vol 2013 ◽  
pp. 1-10 ◽  
Author(s):  
Zhennan Gu ◽  
Janel Suburu ◽  
Haiqin Chen ◽  
Yong Q. Chen

This review focuses on several key areas where progress has been made recently to highlight the role of omega-3 polyunsaturated fatty acid in prostate cancer prevention.


2018 ◽  
Vol 9 (23) ◽  
pp. 4536-4546 ◽  
Author(s):  
Mahmoud Mansour ◽  
Sabrina van Ginkel ◽  
John C. Dennis ◽  
Brandon Mason ◽  
Isra Elhussin ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document